Vialwirebiotech, curated
July 23, 2026, 1:49 AM
May 22, 2026
- 12:00 AM · FT — Pharmaceuticals12:00 AMGenerics drugmaker Sandoz calls for EU to probe alleged China dumping — FT — Pharmaceuticals
May 21, 2026
- 7:39 PM · STAT News
- 5:00 PM · Endpoints News5:00 PM#ASCO26: Key head and neck cancer readouts from J&J, Corbus, Summit, Akero and Bicara — Endpoints News
- 5:00 PM · Endpoints News5:00 PM#ASCO26: New data released for VEGF bispecifics from BioNTech-BMS, Pfizer-3SBio — Endpoints News
- 12:00 PM · BioWorld12:00 PMApellis soars on Biogen deal as biopharma index trails the market — BioWorld
- 12:00 PM · BioWorld12:00 PMTennor’s $80M Hong Kong IPO to fund antibacterial drug pipeline — BioWorld
- 12:00 PM · BioWorld12:00 PMInfex has positive phase IIa data in bronchiectasis; preps for next trial — BioWorld
- 12:00 PM · BioWorld12:00 PMAnother Triumph: Lilly’s triple G agonist scores in obesity — BioWorld
- 11:51 AM · BioPharma Dive11:51 AMRA Capital banks $75M for a biotech SPAC — BioPharma Dive
- 11:39 AM · Endpoints News11:39 AMChina’s drugmakers to take the stage at #ASCO26 — Endpoints News
- 11:33 AM · Pharmaceutical Technology11:33 AMGilead teams up with WHO again to eliminate parasitic tropical disease — Pharmaceutical Technology
- 10:31 AM · Endpoints News10:31 AMBioMarin to seek further approval of Voxzogo in form of short stature — Endpoints News
- 10:22 AM · Endpoints News10:22 AMIncyte signs AI deals with Genesis Molecular AI, Edison Scientific — Endpoints News
- 10:00 AM · Pharmaceutical Executive10:00 AM<![CDATA[Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report ]]> — Pharmaceutical Executive
- 9:02 AM · Endpoints News9:02 AMBMS eyes new campus in Texas; Novartis looks to evict tenant at Slovenian campus — Endpoints News
- 9:00 AM · BioWorld9:00 AMGertrude Biomedical discovers new SOX8 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMIchnos Glenmark Innovation unveils ISB-2301 for solid tumors — BioWorld
- 9:00 AM · BioWorld9:00 AMHansoh identifies new PI3Kα mutant inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMRecludix presents STAT1/3 inhibitors for dermatological diseases — BioWorld
- 9:00 AM · BioWorld9:00 AMCereno Scientific to study CS-585 for antiphospholipid syndrome — BioWorld
- 9:00 AM · BioWorld9:00 AMNampt activators disclosed in Nanjing Reju Therapeutics patent — BioWorld
- 9:00 AM · BioWorld9:00 AMGertrude Biomedical discovers new SOX18 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMRPT-E-037 shows promise as PDAC therapeutic — BioWorld
- 9:00 AM · BioWorld9:00 AMAevisbio patents new cereblon-targeting compounds — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA clears Qihan Biotech’s CAR T therapy QT-019C for clinic — BioWorld
- 9:00 AM · BioPharma Dive9:00 AMIn Alzheimer’s, Bristol Myers sees big promise beyond amyloid — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMNextgen Bioscience reports new S1P1 and S1P4 receptor antagonists — BioWorld
- 7:39 AM · Drug Discovery World7:39 AMUK introduces framework for advanced therapy trials — Drug Discovery World
- 6:45 AM · NYT — Health6:45 AMExperimental Drug Yields Dramatic Weight Loss — NYT — Health
- 6:04 AM · Pharmaceutical Technology6:04 AMFUJIFILM opens new iPSC facility in Madison, US — Pharmaceutical Technology
- 5:30 AM · Pharmaceutical Technology5:30 AMATS 2026: Long-term data show durable benefit of Trikafta for cystic fibrosis — Pharmaceutical Technology
- 5:18 AM · Pharmaceutical Technology5:18 AMBMS and Anthropic collaborate for Claude implementation — Pharmaceutical Technology
- 4:30 AM · STAT News
- 2:27 AM · Bloomberg — Technology2:27 AMFormer Google Deepmind Researcher on New AI Startup — Bloomberg — Technology
- 12:00 AM · TechCrunch12:00 AMImperagen raises £5 million to use quantum physics, AI on enzyme engineering — TechCrunch
May 20, 2026
- 2:48 PM · STAT News
- 2:12 PM · Endpoints News2:12 PMI&I biotech cAMPfield attracts top-tier investors in $180M Series A — Endpoints News
- 12:00 PM · BioWorld12:00 PMImmunovant rises on IMVT-1402 data in difficult-to-treat RA — BioWorld
- 12:00 PM · BioWorld12:00 PMFDA approval advances personalized cancer diagnostics — BioWorld
- 9:49 AM · Drug Discovery World9:49 AMCyclana Bio gets green light to launch endometriosis trial — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMMekanistic’s PI3K/EGFR inhibitor MTX-531 gains IND clearance — BioWorld
- 9:00 AM · BioWorld9:00 AMRe-Aim Therapeutics launches with focus on autoimmune diseases — BioWorld
- 9:00 AM · BioWorld9:00 AMMatter Bio files IND for Lm-LLO-TT for PDAC — BioWorld
- 9:00 AM · BioWorld9:00 AMDropshot advances renal target under Etherna collaboration — BioWorld
- 7:40 AM · Science (News)7:40 AMNot alive, but not dead: disembodied human brains used for drug testing — Science (News)
- 6:15 AM · Pharmaceutical Technology6:15 AMTakeda faces $885m hit after landmark pay-for-delay lawsuit verdict — Pharmaceutical Technology
- 6:00 AM · Pharmaceutical Executive6:00 AM<![CDATA[Positioning TGN-S15 as Synergistic With Keytruda in HPV-Induced Cancers]]> — Pharmaceutical Executive
- 5:42 AM · Drug Discovery World5:42 AMMestag doses first patient in treatment for solid tumours — Drug Discovery World
- 5:22 AM · Pharmaceutical Technology5:22 AMQIAGEN and NVIDIA partner on AI drug discovery — Pharmaceutical Technology
- 4:52 AM · Pharmaceutical Technology4:52 AMSERB signs agreement to acquire Idefirix rights for $133.6m — Pharmaceutical Technology
- 3:55 AM · BioPharma Dive3:55 AMLilly snaps up Engage to advance non-viral genetic medicines — BioPharma Dive